PDF herunterladen
Open Access
CC BY 4.0 · Endosc Int Open 2025; 13: a27313533
DOI: 10.1055/a-2731-3533
Original article

Risk factors for dysplastic lesions in the proximal stomach in patients with familial adenomatous polyposis

Autoren

  • Hicham Bouchiba

    1   Cancer Center Amsterdam, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, the Netherlands

  • Arthur S. Aelvoet

    1   Cancer Center Amsterdam, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, the Netherlands

  • Barbara A.J. Bastiaansen

    1   Cancer Center Amsterdam, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, the Netherlands

  • Patrick M.M. Bossuyt

    2   Department of Epidemiology and Data Science, University of Amsterdam, Amsterdam, the Netherlands

  • Evelien Dekker 

    1   Cancer Center Amsterdam, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, the Netherlands
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Background and study aims

Gastric cancer is a recently recognized challenge in management of familial adenomatous polyposis (FAP), mostly developing in the proximal stomach amid carpeting fundic gland polyposis. Dysplastic lesions in the proximal stomach might be the precursor lesions for gastric cancer in FAP. We aimed to describe incidence of dysplastic lesions in the proximal stomach and to identify risk factors for these dysplastic lesions.

Patients and methods

Data were collected from FAP patients who had undergone esophagogastroduodenoscopy (EGD) between 2015 and 2023 at our academic center. To identify putative risk factors for dysplastic lesions in the proximal stomach, we used multivariable Cox proportional hazard regression modeling.

Results

Among the 196 FAP patients who underwent EGD at our center, 33 (17%) were diagnosed with dysplastic lesions in the proximal stomach. In total 61% were female and median age at diagnosis was 49 years (range 19–80). A total of 105 dysplastic lesions were identified. Ten (9.5%) showed high-grade dysplasia. During the study period, seven patients were diagnosed with gastric cancer. Carpeting fundic gland polyposis (≥ 100 polyps) (hazard ratio [HR] 8.94; P < 0.001), biliary reflux (HR 1.92; P = 0.017), and proton pump inhibitors (HR 1.78; P = 0.014) were significant predictors of dysplastic lesions in the proximal stomach. Advanced Spigelman stage (III/IV) (HR 0.37; P < 0.001) was associated with a significantly lower risk.

Conclusions

Carpeting fundic gland polyposis, biliary reflux, and use of PPIs were identified as putative risk factors for dysplastic lesions in the proximal stomach. Presence of these risk factors should alert endoscopists to assess the stomach more thoroughly.

Keywords

Endoscopy Upper GI Tract - Precancerous conditions & cancerous lesions (displasia and cancer) stomach - Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE) - Endoscopy Lower GI Tract - Polyps / adenomas / ...

Supplementary Material



Publikationsverlauf

Eingereicht: 31. Dezember 2024

Angenommen nach Revision: 08. Oktober 2025

Artikel online veröffentlicht:
06. November 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Hicham Bouchiba, Arthur S. Aelvoet, Barbara A.J. Bastiaansen, Patrick M.M. Bossuyt, Evelien Dekker. Risk factors for dysplastic lesions in the proximal stomach in patients with familial adenomatous polyposis. Endosc Int Open 2025; 13: a27313533.
DOI: 10.1055/a-2731-3533
 

  • References

  • 1 Kinzler KW, Nilbert MC, Su LK. et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-665
    Suche in Google Scholar
  • 2 Bussey HJ, Veale AM, Morson BC. Genetics of gastrointestinal polyposis. Gastroenterology 1978; 74: 1325-1330
    Suche in Google Scholar
  • 3 Ghorbanoghli Z, Bastiaansen BA, Langers AM. et al. Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet 2018; 55: 11-14
    Suche in Google Scholar
  • 4 Sato C, Takahashi K, Sato H. et al. Endoscopic findings and treatment of gastric neoplasms in familial adenomatous polyposis. J Gastric Cancer 2022; 22: 381-394
    Suche in Google Scholar
  • 5 Yamaguchi T, Ishida H, Ueno H. et al. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Japan J Clin Oncol 2016; 46: 310-315
    Suche in Google Scholar
  • 6 Offerhaus GJ, Giardiello FM, Krush AJ. et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992; 102: 1980-1982
    Suche in Google Scholar
  • 7 Walton SJ, Frayling IM, Clark SK. et al. Gastric tumours in FAP. Fam Cancer 2017; 16: 363-369
    Suche in Google Scholar
  • 8 Mankaney G, Leone P, Cruise M. et al. Gastric cancer in FAP: a concerning rise in incidence. Fam Cancer 2017; 16: 371-376
    Suche in Google Scholar
  • 9 Leone PJ, Mankaney G, Sarvapelli S. et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc 2019; 89: 961-968
    Suche in Google Scholar
  • 10 Bianchi LK, Burke CA, Bennett AE. et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6: 180-185
    Suche in Google Scholar
  • 11 Church JM, McGannon E, Hull-Boiner S. et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35: 1170-1173
    Suche in Google Scholar
  • 12 Wood LD, Salaria SN, Cruise MW. et al. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 2014; 38: 389-393
    Suche in Google Scholar
  • 13 Aelvoet AS, Dekker E, Cruise MW. et al. Gastric polyposis and cancer in western patients with familial adenomatous polyposis: Epidemiology, detection, and management. J Natl Compr Canc Netw 2025; 23: e257027
    Suche in Google Scholar
  • 14 Bouchiba H, Aelvoet AS, van Grieken NCT. et al. The challenge of preventing gastric cancer in patients under surveillance for familial adenomatous polyposis. Fam Cancer 2025; 24: 14
    Suche in Google Scholar
  • 15 Martin I, Roos VH, Anele C. et al. astric adenomas and their management in familial adenomatous polyposis. Endoscopy 2021; 53: 795-801 Epub 2020 Nov 5
    Suche in Google Scholar
  • 16 Ngamruengphong S, Boardman LA, Heigh RI. et al. Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract 2014; 12: 4
    Suche in Google Scholar
  • 17 Sasaki K, Kawai K, Nozawa H. et al. Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study. J Gastroenterol 2024;
    Suche in Google Scholar
  • 18 Nakamura S, Matsumoto T, Kobori Y. et al. Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut 2002; 51: 485-489
    Suche in Google Scholar
  • 19 Varanese M, Lattina I, Frattaroli F. et al. Two cases, too little, too late: Surveillance for gastric cancer in patients with FAP. Dig Dis Sci 2023; 68: 4117-4122
    Suche in Google Scholar
  • 20 Trinh TTK, Lee K, Oh JK. et al. Cluster of lifestyle risk factors for stomach cancer and screening behaviors among Korean adults. Sci Rep 2023; 13: 17503
    Suche in Google Scholar
  • 21 Roos VH, Bastiaansen BAJ, Dekker E. Gastric adenomas in familial adenomatous polyposis: You only see them when you know what to look for. Gastrointest Endosc 2018; 88: 403-405
    Suche in Google Scholar
  • 22 Gao W, Huang Y, Lu S. et al. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors. Ann Palliat Med 2021; 10: 2108-2114
    Suche in Google Scholar
  • 23 Tran-Duy A, Spaetgens B, Hoes AW. et al. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 1706-1719.e1705
    Suche in Google Scholar
  • 24 Jalving M, Koornstra JJ, Wesseling J. et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24: 1341-1348
    Suche in Google Scholar
  • 25 McGowan KP, Delgado E, Keeley TM. et al. Region-specific Wnt signaling responses promote gastric polyp formation in patients with familial adenomatous polyposis. JCI Insight 2023; 8: e174546
    Suche in Google Scholar
  • 26 Masaoka T, Suzuki H, Hibi T. Gastric epithelial cell modality and proton pump inhibitor. J Clin Biochem Nutr 2008; 42: 191-196
    Suche in Google Scholar
  • 27 Khalaf M, Brock AS, Castell D. Sporadic fundic gland polyps and gastric acid suppression level. Am J Med Sci 2017; 354: 561-564
    Suche in Google Scholar
  • 28 Fukuda M, Ishigaki H, Sugimoto M. et al. Histological analysis of fundic gland polyps secondary to PPI therapy. Histopathology 2019; 75: 537-545
    Suche in Google Scholar
  • 29 Spigelman AD, Granowska M, Phillips RK. Duodeno-gastric reflux and gastric adenomas: a scintigraphic study in patients with familial adenomatous polyposis. J R Soc Med 1991; 84: 476-478
    Suche in Google Scholar
  • 30 Sobala GM, O'Connor HJ, Dewar EP. et al. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993; 46: 235-240
    Suche in Google Scholar
  • 31 Mankaney GN, Cruise M, Sarvepalli S. et al. Identifying factors associated with detection of sessile gastric polyps in patients with familial adenomatous polyposis. Endosc Int Open 2022; 10: E1080-e1087
    Suche in Google Scholar
  • 32 Aelvoet AS, Pellisé M, Bastiaansen BAJ. et al. Personalized endoscopic surveillance and intervention protocols for patients with familial adenomatous polyposis: the European FAP Consortium strategy. Endosc Int Open 2023; 11: E386-e393
    Suche in Google Scholar
  • 33 Brosens LAA, Wood LD, Offerhaus GJ. et al. Pathology and genetics of syndromic gastric polyps. Int J Surg Pathol 2016; 24: 185-199
    Suche in Google Scholar
  • 34 Calavas L, Rivory J, Hervieu V. et al. Macroscopically visible flat dysplasia in the fundus of 3 patients with familial adenomatous polyposis. Gastrointest Endosc 2017; 85: 679-680
    Suche in Google Scholar
  • 35 Shimamoto Y, Ishiguro S, Takeuchi Y. et al. Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features. Gastrointest Endosc 2021; 94: 1030-1042.e1032
    Suche in Google Scholar